Sapereaude,
Ok, I think understand. The only reason I
Sapereaude,
Ok, I think understand. The only reason I ask is to me the only agreement that I would like to see is with ICON. A spinoff and they a get a piece of L & N and we get to own at least 80% of the spinoff DX company.
Then we get to collect on every test ordered for as many BP as we can get. I don't believe we'll get a single buyout offer for L for the money we "should" get and what GC is willing to accept. Also, I don't trust a single BP. I want returns, but I also want tests to help patients and families down the road.
I don't not want a single JV with a single BP. But that's just me.
And maybe it a language barrier thing, but if you don't know what a JV should look like you might want to read a bit up on them and what the affects could be.
I have been MORE THAN LUCKY to have traveled throughout. Italy. Florence this time of year Is near heaven for me!!! For many years of my life, that would be the place I could live a blink of an eye. But now, Maui is more my path.
If we get the agreements I'm thinking about, I will buy you the Espresso!
Many many returns, CinCin
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...
Continue Reading
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...
Continue Reading
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...
Continue Reading
Top 5 Most Recently Viewed Articles
Examining Investor Feelings Towards Chipotle Mexican Grill Inc Chipotle Mexican Grill Inc (NYSE: CMG) has recently seen a notable change in its short interest, which shares some intriguing insights into investor sentiment. According to the latest data, the short interest as a percentage of float has decreased by 10.42%. Currently, there are approximately 30.53 million...
Continue Reading
Sabio Holdings Inc. Set for CEM AlphaNorth Capital Event In a significant move to bolster investor relations and showcase its innovation in the ad-tech space, Sabio Holdings Inc. (TSXV: SBIO, OTCQB: SABOF) has announced its participation in the esteemed CEM AlphaNorth Capital Event. This event serves as a pivotal platform where growth-stage companies get to interact with...
Continue Reading
Keurig Dr Pepper Declares Quarterly Dividend Keurig Dr Pepper, a renowned beverage company in North America, has revealed that its Board of Directors is set to distribute a regular quarterly cash dividend amounting to $0.23 per share. This announcement underscores the company's commitment to providing value to its shareholders. Dividend Payment Details The declared...
Continue Reading
U.K. Stocks Close with Positive Momentum The latest trading session for U.K. stocks wrapped up on a strong note, showcasing impressive performances across several sectors. The primary drivers behind this rise were gains in Industrial Transportation, General Retailers, and the Beverage sectors, contributing to an overall positive trading atmosphere. Examining Key Index...
Continue Reading
Cardano Aims for the $1 Milestone Cardano (ADA) is positioning itself toward the ambitious $1 mark as it experiences notable gains in the current trading session. Recently, ADA has hit highs of $0.919, generating excitement among cryptocurrency enthusiasts. With Bitcoin (BTC) nearing $100,000, having reached $99,000 in a recent session, many investors are turning their...
Continue Reading